Potential coronavirus treatments could be made for as little as $1, well below their typical price tags in pharmacies, according to an analysis of nine drugs in clinical trials.
If their promise is confirmed in ongoing studies, medicines for Covid-19, including hydroxychloroquine, which President Donald Trump touted as a treatment, and Gilead Sciences Inc.’s remdesivir could be manufactured from $1 to $29 a course, a study published Friday in the Journal of Virus Eradication found.
Results of randomized, controlled trials of several new treatments will emerge in the next three months. If the drugs show promise, there is a potential to massively scale up production and provide low-cost generic supplies worldwide, said Andrew Hill, a senior visiting research fellow in the pharmacology department at Liverpool University and a co-author of the paper.
“At these low prices, anyone needing treatment for coronavirus, in any country, should be able to access the treatment they need,” Hill said in an email. Some of these drugs are sold for hundreds of times more than the cost of production, particularly in the U.S., he added.
“We urgently need worldwide access to effective antiviral treatments for coronavirus to hold back the epidemic for the next 18 months until a vaccine can be produced,” Hill said. “We already know how to mass produce and distribute low-cost drugs to treat HIV, tuberculosis and malaria. It is time to repeat these success stories for coronavirus, but this time much more quickly.”
Manufacturing costs were estimated for nine drugs considered to be leading candidates for the treatment of Covid-19 based on recent reviews and analysis of ongoing clinical trials, Hill and his co-authors said.
Minimum costs of production were estimated from the prices of active pharmaceutical ingredients using established methodology, which had good predictive accuracy for medicines for hepatitis C and HIV among others, according to the study.
Estimated manufacturing costs are shown below.
|DRUG (CHEMICAL NAME)||COST PER TREATMENT (US$)|
“This pricing study shows clearly that potential medicines to treat COVID-19 are not at all expensive to produce and could be priced such that anyone who needs treatment should be able to access it,” said Jessica Burry, a pharmacist with medical aid group Medecins Sans Frontieres’ Access Campaign, in a statement.
- Russia ‘will bomb any country that arrests Putin’ – Former Russian president
- AFCON 2023Q: Antoine Semenyo nets last-ditch winner as Black Stars beat Angola
- Afenyo-Markin pleads for confirmation of ministerial nominees
- Social media reacts to Afena-Gyan’s rejection of Black Meteors call-up
- Beige Bank case: Nyinaku accused of issuing misleading investment certificates to unsuspecting customers
- Ghana v Angola: Jordan Ayew, Kudus start as Chris Hughton era begins
- Funny Face opens up on relationship with Emmanuel Adebayor
- Ashaiman invasion: We have been commended for ridding town of criminals – DG of Armed Forces Public Affairs
- Volta ECG reconnects Ho Airport, GRA, others after payments
- Afena-Gyan turns down Black Meteors invitation for AFCON qualifier against Algeria
- Government needs to block revenue leakages -Prof. Ebo Turkson
- Ghana should move beyond using tax incentives to attract investment – Prof. Turkson
- New tax measures deepening the tax net, not widening it – Dr. Ali Nakyea
- EcoZoil marks World Water Day with beach clean-up and public sensitisation exercises
- Increasing taxes not conditionality for IMF board approval – Dr. Ali Nkayea
- Government’s new tax measures are anti-business – Mark Aboagye
- Ghana is not poor, we are only being poorly managed – Dr. Ali-Nakyea
- Former MP files nomination with a vow to win back Daboya/Makarigu seat
- ECG’s swoop in Nungua District identifies 48 illegal connections
- Playback: PM Express discuss IMF Programme conditionalities
- I didn’t attend the seminary to become a Priest – Rev. Akua Boateng
- Ghana power firms reject move to restructure $1.4bn debt
- God’s Ministers key to national decision-making – New EC Board member
- Don’t expect normal procedures when the military is called into action – Brigadier Aggrey Quarshie
- Agric Minister woos rice investors in Thailand to Ghana